Greenwich LifeSciences, Inc. (GLSI) Key Metrics
GLSI valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $213.6M
- Enterprise value
- $246.7M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 82.0 10-yr median 18.5
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 1.46
GLSI key metrics, 2017–2025
Fiscal year ended December 31, 2025 · U.S. dollarsGLSI valuation Price multiples at each fiscal year-end price.
Price / book+400.5%
805.1
2025 · hover or tap a bar for each year
20172025
Free cash flow yield+1.5 pts
−3.5%
2025 · hover or tap a bar for each year
20172025
GLSI returns How much profit the business earns on the capital it uses.
Return on assets−62.8 pts
−376.9%
2025 · hover or tap a bar for each year
20172025
Asset turnover
0.00
2025 · hover or tap a bar for each year
20172025
GLSI per-share figures Results divided by the shares outstanding at year-end.
Revenue per share
$0.00
2025 · hover or tap a bar for each year
20172025
Earnings per share
−$1.43
2025 · hover or tap a bar for each year
20172025
Free cash flow per share
−$0.73
2025 · hover or tap a bar for each year
20172025
Book value per share−62.6%
$0.03
2025 · hover or tap a bar for each year
20172025
Shares outstanding+4.0%
13.5M
2025 · hover or tap a bar for each year
20172025
GLSI financial health Debt, liquidity and how easily interest is covered.
Net debt−$2.1M
−$6.2M
2025 · hover or tap a bar for each year
20172025
Current ratio−17.4%
1.06
2025 · hover or tap a bar for each year
20172025
GLSI efficiency & capital use Working capital cycle and where the cash goes.
Days payables outstanding+644,181 days
787,595 days
2025 · hover or tap a bar for each year
20172025
GLSI valuation history
Fiscal year-endToday9-year median
GLSI returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
GLSI debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
GLSI cash returned to shareholders
DividendsBuybacksFree cash flow
GLSI price vs earnings per share
Share price at year-endEPS (right axis)
GLSI key metrics
2017–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||
| Market capitalization | $284.4M | $146.2M | $135.2M | $196.3M | $314.9M | $463.3M | — | — | — |
| Enterprise value | $278.2M | $142.1M | $128.2M | $182.8M | $287.7M | $434.9M | — | — | — |
| Price / book | 805.1 | 160.9 | 20.2 | 14.9 | 11.7 | 16.8 | — | — | — |
| Earnings yield | −6.8% | −11.9% | −6.6% | −4.0% | −1.5% | −0.4% | — | — | — |
| Free cash flow yield | −3.5% | −5.0% | −4.8% | −3.2% | −1.4% | −0.2% | — | — | — |
| Shareholder yield (dividends + buybacks) | — | — | 0.0% | 3.8% | 0.0% | 0.0% | — | — | — |
| Share price at fiscal year-end | $21.01 | $11.23 | $10.52 | $15.20 | $24.33 | $36.47 | — | — | — |
| Per share | |||||||||
| Revenue per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Earnings per share | −$1.43 | −$1.34 | −$0.69 | −$0.61 | −$0.35 | −$0.15 | −$0.29 | −$0.14 | −$0.13 |
| Operating cash flow per share | −$0.73 | −$0.56 | −$0.50 | −$0.48 | −$0.33 | −$0.09 | −$0.02 | −$0.01 | −$0.01 |
| Free cash flow per share | −$0.73 | −$0.56 | −$0.50 | −$0.48 | −$0.33 | −$0.09 | −$0.02 | −$0.01 | −$0.01 |
| Cash per share | $0.46 | $0.31 | $0.54 | $1.04 | $2.10 | $2.26 | $0.00 | $0.01 | $0.00 |
| Book value per share | $0.03 | $0.07 | $0.52 | $1.02 | $2.07 | $2.18 | −$0.11 | −$0.85 | −$0.73 |
| Tangible book value per share | $0.03 | $0.07 | $0.52 | $1.02 | $2.07 | $2.17 | −$0.12 | −$0.85 | −$0.73 |
| Capex per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Debt per share | — | — | — | — | — | $0.02 | $0.05 | $0.04 | — |
| Shares outstanding | 13.5M | 13.0M | 12.8M | 12.9M | 12.9M | 12.7M | 11.7M | 12.0M | 11.7M |
| Change in shares outstanding | +4.0% | +1.3% | −0.5% | −0.2% | +1.9% | +8.2% | −1.9% | +1.9% | — |
| Returns & profitability | |||||||||
| Return on equity (ROE) | — | −457.7% | −89.3% | −39.1% | −16.8% | −14.2% | — | — | — |
| Return on assets (ROA) | −376.9% | −314.1% | −86.9% | −38.5% | −16.4% | −13.0% | — | — | — |
| Return on tangible assets | −313.3% | −425.6% | −127.2% | −58.1% | −16.8% | −6.5% | — | — | — |
| Financial health | |||||||||
| Total debt | — | — | — | — | — | $275,154 | $635,154 | $420,154 | — |
| Cash & short-term investments | $6.2M | $4.1M | $7.0M | $13.5M | $27.2M | $28.7M | $6,835 | $85,102 | $54 |
| Net debt | −$6.2M | −$4.1M | −$7.0M | −$13.5M | −$27.2M | −$28.4M | $628,319 | $335,052 | −$54 |
| Debt / equity | — | — | — | — | — | 0.01 | — | — | — |
| Debt / assets | — | — | — | — | — | 0.01 | 23.81 | 3.87 | — |
| Current ratio | 1.06 | 1.28 | 23.74 | 51.23 | 70.63 | 27.41 | 0.00 | 0.12 | 0.00 |
| Quick ratio | 1.06 | 1.28 | 23.74 | 51.23 | 70.63 | 27.41 | 0.00 | 0.12 | 0.00 |
| Interest coverage | — | — | — | -37.4 | -168.0 | — | — | — | — |
| Working capital | $353,217 | $906,847 | $6.7M | $13.2M | $26.8M | $27.6M | −$1.4M | −$643,497 | −$557,449 |
| Invested capital | −$5.8M | −$3.2M | −$289,015 | −$253,902 | −$372,557 | −$754,111 | −$722,099 | −$9.8M | −$8.5M |
| Tangible asset value | $353,217 | $906,847 | $6.7M | $13.2M | $26.8M | $27.6M | −$1.4M | −$10.1M | −$8.5M |
| Net current asset value | $353,217 | $906,847 | $6.7M | $13.2M | $26.8M | $27.6M | −$1.4M | −$10.1M | −$8.6M |
| Graham net-net per share | $0.03 | $0.07 | $0.52 | $1.02 | $2.07 | $2.17 | −$0.12 | −$0.85 | −$0.73 |
| Capital allocation | |||||||||
| Share buybacks (net) | — | — | $0 | $7.5M | $0 | $0 | — | — | $90,000 |
| Capex / depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | |||||||||
| Days payables outstanding | 787,595.2 | 143,414.0 | 12,950.7 | 22,316.8 | 47,081.0 | 72,882.7 | 50,994.0 | 22,196.6 | 16,306.7 |
| Payables turnover | 0.00 | 0.00 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average payables | $3.8M | $1.4M | $128,158 | $220,845 | $465,908 | $720,640 | $503,932 | $219,351 | $161,146 |
| Intangibles / total assets | 0.0% | 0.0% | 0.1% | 0.1% | 0.0% | 0.1% | 74.4% | 21.6% | 0.0% |
Computed from GLSI's annual financial statements (latest annual report filed June 1, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
GLSI valuation and financial ratios
The share count rose 15.3% from 11.7M to 13.5M over 8 years.
See the GLSI income statement, the GLSI chart for price history, or the GLSI stock overview for the latest quote and news.
GLSI key metrics FAQ
What is Greenwich LifeSciences's free cash flow yield?
Greenwich LifeSciences generated -$9.9 million of free cash flow in fiscal 2025, a free cash flow yield of −3.5% on its market value at year-end ($284.4 million).
What is Greenwich LifeSciences's current ratio?
Greenwich LifeSciences's current ratio was 1.06 at the end of fiscal 2025: current assets were 1.06 times current liabilities.